• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec24
Oppenheimer Analyst Reiterates Buy Rating on enGene Holdings
14:16
Dec23
Engene released FY2025 Annual Earnings on December 22 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.2946 (forecast USD -2.1167)
04:00
Engene released FY2025 Q4 earnings on December 22 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.7372 (forecast USD -0.5691)
04:00
Dec2
ENGENE's Product Selected for FDA Pilot Program
13:18
enGene bladder cancer drug trial yields positive results
12:47
Nov12
Oppenheimer Analyst Reiterates Buy Rating and Price Target for enGene Holdings
13:02

Schedules & Filings

Schedules
Filings
Dec22
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -37.88 M, EPS -0.7372

Sep11
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -28.99 M, EPS -0.5673

Jun12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.82 M, EPS -0.5059

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
RPGL
0.5202
+97.57%
+0.252
BNAI
2.058
+71.50%
+0.831
SOPA
2.921
+60.51%
+1.110
CCTG
0.2080
+59.63%
+0.079
GVH
3.600
+38.46%
+1.050
MASK
0.2468
+34.86%
+0.063
ASPC
31.020
+29.20%
+7.010
AFJKR
0.4800
+26.32%
+0.100
ORBS
2.070
+24.34%
+0.405
FTEL
0.8989
+23.15%
+0.168
View More